Bringing the fundamentals into focus…
Back to BioNTech SE
How BioNTech SE stacks up
BNTX · against 102 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #94 of 103 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score10 peers with a valuation score of 0–9, including BNTX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -2.9% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -21.9% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 63% of peers. Free cash flow yield: 0.7% vs peer median 0.0%
Metric by metric
Position: dot = BNTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BNTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 101 reported | Not reported | 3.2% | — | — | 30% |
| EBITDA yieldHigher is better · 103 reported | -21.9% | 5.9% | 0% | 50% | |
| Free cash flow yieldHigher is better · 62 reported | 2.3% | 3.9% | 26% | 20% | |
| Book yieldHigher is better · 97 reported | 98.8% | 21.7% | 98% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around BNTX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 2 | 21.5B USD | 95 | 60 | |
| 4 | 11.6B USD | 94 | 58 | |
| 4 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 90 | 20.0B AUD (≈$13.2B) | 38 | 77 | |
| 92 | 16.5B USD | 36 | 37 | |
| 93 | 10.1B EUR (≈$11.1B) | 29 | ||
| 94 | 14.5B USD | 8 | 30 | |
| 94 | 21.8B USD | 8 | 32 | |
| 94 | 33.3B USD | 8 | 24 | |
| 94 | 23.5B USD | 8 | 27 | |
| 94 | 13.7B USD | 8 | 45 | |
| 94 | 22.8B USD | 8 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score